Comparison of the enhancement of plasma glucose levels in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats by oral administration of sucrose or maple syrup

Journal of Oleo Science

Volumn 62, Issue 9, 2013, Pages 737-743

  Nagai, Noriaki ^a   Ito, Yoshimasa ^a   Taga, Atsushi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Insulin; Maple syrup; OGT test; Otsuka Long Evans Tokushima Fatty rat; Plasma glucose; Type 2 diabetes mellitus

Indexed keywords

CELL DYSFUNCTION; MAPLE SYRUP; ORAL ADMINISTRATION; OTSUKA LONG-EVANS TOKUSHIMA FATTY RATS; PLASMA GLUCOSE; PLASMA GLUCOSE LEVEL; TYPE 2 DIABETES MELLITUS; TYPE-2 DIABETES;

GLUCOSE; INSULIN; PLASMAS; SUGAR (SUCROSE);

RATS;

INSULIN; NUTRITIVE SWEETENER; GLUCOSE BLOOD LEVEL; SUGAR INTAKE;

ACER; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HUMAN; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; RAT; SUGAR INTAKE; ADMINISTRATION AND DOSAGE; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; PHARMACOLOGY;

ACER; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HUMANS; INSULIN; MALE; NUTRITIVE SWEETENERS; RATS; RATS, INBRED OLETF;

EID: 84883469567     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.62.737     Document Type: Article

References (31)

1. Haffner, S. M.; Valdez, R. A.; Hazuda, H. P.; Mitchell, B. D.; Morales, P. A.; Stern, M. P. Prospective analysis of the IR syndrome (syndrome X). Diabetes 41, 715-722 (1992).
2. Isomaa, B.; Almgren, P.; Tuomi, T.; Forsen, B.; Lahti, K; Nissen, M.; Taskinen, M.R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689 (2001).
3. Porte, D. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40, 166-180 (1991).
4. DeFronzo, R. A.; Bonadonna, R. C; Ferrannini, E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368 (1992).
5. Yki, J. H. Glucose toxicity. Endocrine. Rev. 13, 415-431(1992).
6. Vinik, A.; Pittenger, G.; Rafaeloff, R.; Rosenberg, L.; Duguid, W. Determinants of pancreatic islet cell mass: a balance between neogenesis and senescence/apop-tosis. Diabetes Rev. 4, 235-263 (1996).
7. Matsuoka, T.; Kajimoto, Y.; Watada, H.; Kaneto, H.; Kishimoto, M.; Umayahara, Y.; Fujitani, Y; Kamada, T.; Kawamori, R.; Yamasaki, Y Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin Invest. 99, 144-150(1997).
8. Kaneto, H.; Fujii, J.; Myint, T.; Miyazawa, N.; Islam, K.N.; Kawasaki, Y; Suzuki, K; Nakamura, M.; Tatsumi, H.; Yamasaki, Y; Taniguchi, N. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the gly-cation reaction. Biochem. J. 320, 855-863(1996).
9. Tiedge, M.; Lortz, S.; Drinkgern, J.; Lenzen, S. Relation between antioxidant enzyme gene expression and an-tioxidative defense status of Insulin-producing cells. Diabetes. 46, 1733-1742(1997).
10. Ball, D. W. The chemical composition of maple syrup. Journal of Chemical Education 84, 1647-1650 (2007).
11. Davison, R. M.; Young, H. Abscisic acid content of xy-lem sap. Planta(Berl.) 109, 95-98(1973).
12. Perkins, T. D.; van den Berg, A. K. Maple syrupproduc-tion, composition, chemistry, and sensory characteristics. Adv. Food Nutr. Res. 56, 101-143(2009).
13. Taga, A.; Sato, A.; Suzuki, K.; Takeda, M.; Kodama, S. Simple determination of a strongly aromatic compound, sotolon, by capillary electrophoresis. J. Oleo Sci. 61, 45-48(2012).
14. Taga, A.; Kodama, S. Analysis of reducing carbohydrates and fructosyl saccharides in maple syrup and maple sugar by CE. Chromatographia. 75, 1009-1016 (2012).
15. Li, L.; Seeram, N. P. Maple syrup phytochemicals include lignans, coumarins, a stilbene, and other previously unreported antioxidant phenolic compounds. Agric Food Chem. 58, 11673-11679(2010).
16. Li, L.; Seeram, N. P. Further investigation into maple syrup yields 3 new lignans, a new phenylpropanoid, and 26 other phytochemicals. Agric Food Chem. 59, 7708-7716(2011).
17. Li, L.; Seeram, N. P. Quebecol, a novel phenolic compound isolated from Canadian maple syrup. J. Funct. Foods. 2, 125-128(2011).
18. Legault, J.; Girard-Lalancette, K.; Grenon, C; Dussault, C; Pichette, A., Antioxidant activity, inhibition of nitric oxide overproduction, and in vitro antip- roliferative effect of maple sap and syrup from Acer saccharum. J. Med. Food 13, 460-468 (2010).
19. Apostolidis E., Li L., Lee C, Seeram NP. In vitro evaluation of phenolic-enriched maple syrup extracts for inhibition of carbohydrate hydrolyzing enzymes relevant to type 2 diabetes management. J. Funct. Foods. 3, 100-106(2011).
20. Kawano, K.; Hirashima, T.; Mori, S.; Saitoh, Y.; Kuro-sumi, M.; Natori, T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41, 1422-1428(1992).
21. Prager R., Abramovici A., Liban E., Laron Z. Histo-pathological changes in the placenta of streptozotocin induced diabetic rats. Diabetologia. 10, 89-91 (1974).
22. Wakuta M., Morishige N., Chikama T., Seki K., Nagano T., Nishida T. Invest. Ophthalmol. Vis. Sci. 48, 590-596(2007).
23. Ishida, K.; Mizuno, A.; Min, Z.; Sano, T.; Shima, K. Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism. 44, 940-945(1995).
24. Sato, T.; Asahi, Y.; Toide, K.; Nakayama, N. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia. 38, 1033-1041(1995).
25. Yabuki, A.; Tahara, T; Taniguchi, K.; Matsumoto, M.; Suzuki, S. Neuronal nitric oxide synthase and cycloox-ygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats. Exp. Anim. 55, 17-25(2006).
26. Hirashima, T; Man, Z. W.; Mori, S.; Kawano, K. OLETF rat. Diabetes Frontier 9, 477-480 (1998).
27. Minami, A.; Ishimura, N.; Sakamoto, S.; Takishita, E.; Mawatari, K.; Okada, K.; Nakaya, Y Effect of eicosa-pentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Br. J. Nutr. 87, 157-162(2002).
28. Nagai, N.; Murao, T; Okamoto, N.; Ito, Y Disulfiram reduces elevated blood glucose levels in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes. J. Oleo Sci. 58, 485-490 (2009).
29. Nagai, N.; Murao, T; Ito, Y; Okamoto, N.; Sasaki, M. Enhancing effects of sericin on corneal wound healing in Otsuka Long-Evans Tokushima fatty rats as a model of human type 2 diabetes. Biol. Pharm. Bull. 32, 1594-1599(2009).
30. Nagai, N.; Murao, T; Okamoto, N.; Ito, Y Kinetic analysis of the rate of corneal wound healing in Otsuka long-evans Tokushima Fatty rats, a model of type 2 diabetes mellitus. J. Oleo Sci. 59, 441-449 (2010).
31. Nagai, N.; Murao, T; Ito, Y; Okamoto, N.; Okamura, H. Involvement of interleukin 18 in lens opacification of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. Curr Eye Res. 36, 497-506 (2011).